Hypoxia-inducible factor 1 (HIF-1) is a transcription factor functioning in cellular adaptive responses to hypoxia. Recent studies have suggested that HIF-1 activity is upregulated by one of the important circadian clock genes, period circadian clock 2 (PER2); however, its underlying mechanism remains unclear. Here, we show that PER2 functions as an effector protein for the recruitment of HIF-1a to its cognate enhancer sequence, the hypoxia-response element (HRE). We found that the forced expression of PER2 enhanced HIF-1 activity without influencing expression levels of the regulatory subunit of HIF-1, HIF-1a, at either mRNA or protein levels. A series of coimmunoprecipitation-based experiments revealed that PER2 interacted with HIF-1a and facilitated the recruitment of HIF-1a to HRE derived from vascular endothelial growth factor (VEGF) promoter. The PER2-mediated activation of HIF-1 was observed only when the asparagine residue at position 803 of HIF-1a (HIF-1a N803) was kept unhydroxylated by hypoxic stimulation, by introducing an N803A point mutation, or by an inhibitor of N803-dioxygenase, deferoxamine. However, the extent of PER-2-HIF-1a interaction was equivalent regardless of the N803 hydroxylation status. Taken together, these results suggest that, with the help of an unknown sensor molecule for the N803 hydroxylation status, PER2 functions as an effector molecule for the recruitment of HIF-1 to promoter regions of its downstream genes. Our findings reveal a novel regulatory step in the activation of HIF-1, which can be targeted to develop therapeutic strategies against HIF-1-related diseases, such as cancers.Abbreviations 5 0 -UTR, 5 0 untranslated region; a.a., amino acid; CBP, CREB-binding protein; CDS, coding sequence; DFO, deferoxamine; FIH-1, factorinhibiting HIF-1; Gal4 DBD, Gal4 DNA-binding domain; HDAC, histone deacetylase; HIF-1, hypoxia-inducible factor 1; HRE, hypoxia-response element; IDH3, isocitrate dehydrogenase 3; LY6E, lymphocyte antigen 6 complex, locus E; mTOR, mammalian target of rapamycin; ODD, oxygen-dependent degradation domain; PER2, period circadian clock 2; PHDs, prolyl-4-hydroxylases; PI3K, phosphatidylinositol 3 kinase; PKC, protein kinase C; pVHL, VHL protein; qRT-PCR, quantitative real-time reverse transcriptase PCR; TAD, transactivation domain; UCHL1, ubiquitin C-terminal hydrolase L1; VEGF, vascular endothelial growth factor; VHL, von-Hippel Lindau.